DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Merli G, Spiro TE, Olsson CG. , et al; Enoxaparin Clinical Trial Group.
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
Ann Intern Med 2001;
134 (03) 191-202
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.